Sponsors

Molecular diagnostics aids virology workflow

The DxN VERIS, available from Beck Diagnostics, is a fully automated system for molecular diagnostics that is simple to use. DxN VERIS has all necessary consumables and reagents onboard, so tests can be up and running in less than 10 minutes, as there is no lengthy set-up.

Considerable savings are claimed in manpower and hands-on time as extraction, amplification and detection are all undertaken in the one system. DxN VERIS also provides true single-sample, random access, allowing multiple assays and samples to be run at the same time, enabling laboratories to go from sample to first result in as little as 70 minutes. Fully CE-marked, the system currently has assays for human immunodeficiency virus (HIV-1), hepatitis C virus (HCV), hepatitis B virus (HBV) and human cytomegalovirus (CMV), with other assays in development. Assays are supplied in single cartridge system so there are no empty wells, thereby reducing wastage and consumable costs. “Independent evaluations of the DxN VERIS Molecular Diagnostics System and assays are of great interest to virology laboratories,” said Richard Creager, senior vice president, Molecular Diagnostics Business Unit, and chief scientific officer at Beckman Coulter Diagnostics. “Their findings underpin the workflow advantages that DxN VERIS can bring to the modern laboratory, dramatically reducing both hands-on time to first result for HIV-1, HCV, HBV and CMV viral loads.” [email protected]

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026